Literature DB >> 14736754

Serial magnetization transfer imaging in acute optic neuritis.

S J Hickman1, A T Toosy, S J Jones, D R Altmann, K A Miszkiel, D G MacManus, G J Barker, G T Plant, A J Thompson, D H Miller.   

Abstract

In serial studies of multiple sclerosis lesions, reductions in magnetization transfer ratio (MTR) are thought to be due to demyelination and axonal loss, with later rises due to remyelination. This study followed serial changes in MTR in acute optic neuritis in combination with clinical and electrophysiological measurements to determine if the MTR changes over time mirror the picture in multiple sclerosis lesions, further validating MTR as a marker of tissue integrity. Twenty-nine patients were recruited who had acute optic neuritis for a median of 13 days (range 7-24 days) since the onset of visual symptoms. A clinical examination and measurement of visual evoked potentials (VEP) was performed on each patient. Their optic nerves were imaged with a fat-saturated fast spin echo (FSE) sequence and a magnetization transfer sequence. Twenty-one had multiple subsequent examinations over the course of 1 year. In addition, 27 control subjects had their optic nerves imaged up to three times over 1 year. A blinded observer segmented the optic nerves from the MTR maps. Lesions were defined on the acute FSE images and, from the coordinates, the ratio of mean lesion MTR : healthy nerve MTR (lesion ratio) was calculated for each dataset. The time-averaged mean MTR in control optic nerves was 47.7 per cent units (pu). In diseased optic nerves, baseline mean MTR was 47.3 pu, with a mean lesion ratio of 0.98. The diseased optic nerve MTR and lesion ratio declined over time with a nadir at about 240 days at a mean MTR value of 44.2 pu and mean lesion ratio of 0.91. Subsequently, diseased optic nerve MTR appeared to rise; after 1 year the diseased optic nerve mean MTR was 45.1 pu (mean lesion ratio 0.93), although the difference was not significant compared with the nadir value. For each 0.01 increase in time-averaged lesion ratio logMAR visual acuity recovery improved by 0.03 (95% CI, 0.002, 0.08, P = 0.02). Time-averaged VEP central field latency was shorter by 6.1 ms (95% CI 1.5, 10.7, P = 0.012) per 1 pu rise in time-averaged diseased optic nerve MTR. The early fall in diseased optic nerve MTR is consistent with demyelination and Wallerian degeneration of transected axons. The late nadir compared with studies of multiple sclerosis lesions may have been due to slow clearance of myelin debris. Remyelination may have influenced subsequent MTR changes. The observations support using MTR to monitor symptomatic demyelinating lesions.

Entities:  

Mesh:

Year:  2004        PMID: 14736754     DOI: 10.1093/brain/awh076

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  37 in total

1.  Quantitative MR imaging of two-pool magnetization transfer model parameters in myelin mutant shaking pup.

Authors:  Alexey Samsonov; Andrew L Alexander; Pouria Mossahebi; Yu-Chien Wu; Ian D Duncan; Aaron S Field
Journal:  Neuroimage       Date:  2012-06-01       Impact factor: 6.556

Review 2.  Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

Authors:  Madhan Kolappan; Andrew P D Henderson; Thomas M Jenkins; Claudia A M Wheeler-Kingshott; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

3.  Improved diffusion tensor imaging of the optic nerve using multishot two-dimensional navigated acquisitions.

Authors:  Ha-Kyu Jeong; Blake E Dewey; Jane A T Hirtle; Patrick Lavin; Subramaniam Sriram; Siddharama Pawate; John C Gore; Adam W Anderson; Hakmook Kang; Seth A Smith
Journal:  Magn Reson Med       Date:  2014-09-26       Impact factor: 4.668

4.  New developments in the treatment of optic neuritis.

Authors:  Thomas M Jenkins; Ahmed T Toosy
Journal:  Eye Brain       Date:  2010-06-17

5.  Optic neuritis in neuromyelitis optica.

Authors:  Marc H Levin; Jeffrey L Bennett; A S Verkman
Journal:  Prog Retin Eye Res       Date:  2013-03-30       Impact factor: 21.198

Review 6.  Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains.

Authors:  Andrew L Alexander; Samuel A Hurley; Alexey A Samsonov; Nagesh Adluru; Ameer Pasha Hosseinbor; Pouria Mossahebi; Do P M Tromp; Elizabeth Zakszewski; Aaron S Field
Journal:  Brain Connect       Date:  2012-01-27

Review 7.  Remyelinating Pharmacotherapies in Multiple Sclerosis.

Authors:  Riley M Bove; Ari J Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

8.  Diffusion tensor imaging in acute optic neuropathies: predictor of clinical outcomes.

Authors:  Robert T Naismith; Junqian Xu; Nhial T Tutlam; Samantha Lancia; Kathryn Trinkaus; Sheng-Kwei Song; Anne H Cross
Journal:  Arch Neurol       Date:  2011-09-12

Review 9.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

10.  Subcortical biophysical abnormalities in patients with mood disorders.

Authors:  A Kumar; S Yang; O Ajilore; M Wu; R Charlton; M Lamar
Journal:  Mol Psychiatry       Date:  2013-07-23       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.